Business
Chimeric (ASX:CHM) share price drops despite cancer trial update
Image Source: Getty Images
The Chimeric Therapeutics Ltd (ASX: CHM) share price has fallen today. It coincides with the drug development company’s update on its cancer cell therapy.
At market’s close, the Chimeric share price was trading at 29 cents, down…
Continue Reading
-
Noosa News22 hours agoRallies under way as nationwide support for Palestine surges
-
General19 hours agoThousands flood cities demanding action on Palestine
-
Noosa News22 hours agoHusband charged after beloved Brisbane nurse Carra Luke allegedly stabbed to death in Taigum home
-
General21 hours agoTens of thousands protest in nationwide action against war in Gaza